SEC Form 4 · accession 0001572426-17-000036
Nexvet Biopharma plc · NVET
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Bernard Payne
Director
Period of report
Jul 31, 2017
Accepted (ET)
Aug 2, 2017 · 9:40 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001618561
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Jul 31, 2017 | D | 10,800 | $6.72 | D | 0 | D | |
| Ordinary SharesF1,F2 | Jul 31, 2017 | D | 6,195 | $6.72 | D | 0 | I | John B. Payne Living A/C |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Disposed of pursuant to a transaction agreement between the Issuer, Zoetis Inc. ("Zoetis") and Zoetis Belgium S.A., a wholly-owned subsidiary of Zoetis ("Bidco"), pursuant to which Bidco acquired the Issuer.
- F2The reporting person has sole voting and dispositive power with respect to these reported securities.